Colitis

Colitis is treatable*

The diagnosis of ulcerative colitis confronts those affected with a painful and often highly disabling chronic bowel disease which, in contrast to Crohn’s disease, primarily affects the colon and rectum, spreading there as continuous inflammation of the mucosa. Bloody diarrhea, painful cramps, and the constant, often panicky urge to use the restroom dictate the patients’ daily routine. The fear of the next severe flare-up and the long paths of suffering place an enormous physical and psychological burden on those affected, especially when conventional medications reach their long-term limits.

How we treat Colitis and what improvements can be achieved*

We aim to specifically interrupt the chronic inflammatory spiral in the colon and sustainably regenerate the destroyed intestinal mucosa. Through the use of individually tailored biological signaling molecules and regenerative protocols, we support the weakened tissue in its restoration. We act in an anti-inflammatory and immunomodulatory manner directly within the affected intestinal segment in order to strengthen the barrier function of the mucosa, rapidly curb acute flare-ups, and promote stable, symptom-free phases.

What is the scientific background*

Ulcerative colitis is explained by a dysfunction of the mucosal immune response, in which the immune system mistakenly reacts to harmless gut bacteria and triggers a permanent inflammatory cascade leading to painful ulcers (ulcerations). Since the colon’s intrinsic repair capacity is exhausted during this chronic course, regenerative medicine targets biological signaling molecules: they modulate the local immune response, activate reparative processes, and initiate essential ‘mucosal healing’ to restore the integrity of the intestinal tissue.

* The contents serve to provide understandable orientation and do not replace individual medical advice. Indication, implementation and chances of success are always personally checked by a doctor.